A retrospective study of definitive chemoradiotherapy for elderly patients with esophageal cancer

American Journal of Clinical Oncology: Cancer Clinical Trials

Volumn 30, Issue 6, 2007, Pages 607-611

  Takeuchi, Satoshi ^a   Ohtsu, Atsushi ^a   Doi, Toshihiko ^a   Kojima, Takashi ^a   Minashi, Keiko ^a   Mera, Kiyomi ^a   Yano, Tomonori ^a   Tahara, Makoto ^a   Muto, Manabu ^a   Nihei, Keiji ^a  

^a NATIONAL CANCER CENTER HOSPITAL EAST   (Japan)

Author keywords

Definitive chemoradiotherapy; Elderly patients; Esophageal cancer

Indexed keywords

CISPLATIN; FLUOROURACIL;

ADULT; AGED; ANEMIA; ARTICLE; CANCER CHEMOTHERAPY; CANCER PATIENT; CANCER RADIOTHERAPY; CANCER RECURRENCE; CANCER SURVIVAL; CAUSE OF DEATH; DRUG FATALITY; DRUG INFUSION; ESOPHAGITIS; ESOPHAGUS CANCER; FEMALE; HUMAN; KIDNEY DISEASE; LEUKOPENIA; MAJOR CLINICAL STUDY; MALE; MEDICAL RECORD REVIEW; NAUSEA AND VOMITING; PATIENT SELECTION; RADIATION DOSE; RETROSPECTIVE STUDY; STATISTICAL SIGNIFICANCE; STOMATITIS; THROMBOCYTOPENIA;

AGED; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; CAUSE OF DEATH; COMBINED MODALITY THERAPY; COMORBIDITY; ESOPHAGEAL NEOPLASMS; FEMALE; FLUOROURACIL; HEMATOLOGIC DISEASES; HUMANS; JAPAN; LACTATES; MALE; NEOPLASM RECURRENCE, LOCAL; NEOPLASM STAGING; PATIENT COMPLIANCE; PHENOLS; RADIATION DOSAGE; RETROSPECTIVE STUDIES; SURVIVAL RATE;

EID: 37349102673     PISSN: 02773732     EISSN: 1537453X     Source Type: Journal    
DOI: 10.1097/COC.0b013e3180ca7c84     Document Type: Article

References (14)

1. Baba M, Aikou T, Yoshinaka H, et al. Long-term results of subtotal esophagectomy with three-field lymphadenectomy for carcinoma of the thoracic esophagus. Ann Surg. 1994;219:310-316.
2. Herskovic A, Martz K, Al-Sarraf M, et al. Combined chemotherapy and radiotherapy compared with radiotherapy alone in patients with cancer of the esophagus. N Engl J Med. 1992;326:1593-1598.
3. Hironaka S, Ohtsu A, Boku N, et al. Nonrandomized comparison between definitive chemoradiotherapy and radical surgery in patients with T(2-3)N(any) M(0) squamous cell carcinoma of the esophagus. Int J Radiat Oncol Biol Phys. 2003;57:425-433.
4. Al-Sarraf M, Martz K, Herskovic A, et al. Progress report of combined chemoradiotherapy versus radiotherapy alone in patients with esophageal cancer. J Clin Oncol. 1997;15:277-284.
5. Cooper JS, Guo MD, Herskovic A, et al. Chemoradiotherapy of locally advanced esophageal cancer: long-term follow-up of a prospective randomized trial (RTOG 85-01). Radiation Therapy Oncology Group. JAMA. 1999;281:1623-1627.
6. Minsky BD, Pajak TF, Ginsberg RJ, et al. INT 0123 (Radiation Therapy Oncology Group 94-05) Phase III trial of combined-modality therapy for esophageal cancer: high-dose versus standard-dose radiation therapy. J Clin Oncol. 2002;20:1167-1174.
7. Wilson KS, Lim JT. Primary chemo-radiotherapy and selective oesophagectomy for oesophageal cancer: goal of cure with organ preservation. Radiother Oncol. 2000;54:129-134.
8. Fentiman IS, Tirelli U, Monfardini S, et al. Cancer in the elderly: why so badly treated? Lancet. 1990;335:1020-1022.
9. Miller AB, Hoogstraten B, Staquet M, et al. Reporting results of cancer treatment. Cancer. 1981;47:207-214.
10. National Cancer Institute. The revised common toxicity criteria: version 2.0 CTEP. Available at: http://ctep.info.nih.gov, 1999.
11. Gridelli C. The ELVIS trial: a phase III study of single-agent vinorelbine as first-line treatment in elderly patients with advanced non-small cell lung cancer. Elderly Lung Cancer Vinorelbine Italian Study. Oncologist. 2001;6(suppl 1):4-7.
12. Pignon T, Gregor A, Schaake Koning C, et al. Age has no impact on acute and late toxicity of curative thoracic radiotherapy. Radiother Oncol. 1998;46:239-248.
13. Ishikura S, Nihei K, Ohtsu A, et al. Long-term toxicity after definitive chemoradiotherapy for squamous cell carcinoma of the thoracic esophagus. J Clin Oncol. 2003;21:2697-2702.
14. Ohtsu A, Boku N, Muro K, et al. Definitive chemoradiotherapy for T4 and/or M1 lymph node squamous cell carcinoma of the esophagus. J Clin Oncol. 1999;17:2915-2921.